SCHEMBL2448071

SCHEMBL2448071

COc1cn2cc(Br)nc(N3CCOCC3)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 8/20 0.41
PIK3R1 P27986 6/20 0.41
CYP2C19 P33261 1/20 0.40
HTR2C P28335 1/20 0.40
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
BLM P54132 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MAPK1 P28482 2/20 0.38
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10092233 0.83 PIK3CA (0.55) PIK3CAPIK3R1HTR2CKMT2AALDH1A1
SCHEMBL6937939 0.80 PIK3R1 (0.47) PIK3CAPIK3R1CYP2C19PDE10A
SCHEMBL26072464 0.78 PIK3R1 (0.46) PIK3CAPIK3R1HTR2CMTOR
SCHEMBL10092229 0.77 PIK3CA (0.49) PIK3CAPIK3R1HTR2CMTOR
SCHEMBL5561919 0.77 HTR2C (0.39) PIK3CAPIK3R1HTR2CALDH1A1GAA
SCHEMBL5560455 0.77 PIK3CA (0.58) PIK3CAPIK3R1HTR2CMTOR
SCHEMBL13896920 0.77 PIK3CA (0.45) PIK3CAPIK3R1HTR2CMTOR
SCHEMBL10092212 0.77 PIK3R1 (0.45) PIK3CAPIK3R1HTR2CMTOR
SCHEMBL7318610 0.77 CTSK (0.43) PIK3CAPIK3R1HTR2CALDH1A1KDM4E
SCHEMBL5557353 0.76 PIK3CA (0.44) PIK3CAPIK3R1CYP2C19ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011110545-A1 IMIDAZO [1, 2 -A] PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES JANSSEN PHARMACEUTICA NV (BE) 2011-09-15 WO disclosed